DiscoverThe Lancet HIVIn Conversation With... Kelly Dooley and Gavin Churchyard
In Conversation With... Kelly Dooley and Gavin Churchyard

In Conversation With... Kelly Dooley and Gavin Churchyard

Update: 2020-06-03
Share

Description

Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

In Conversation With... Kelly Dooley and Gavin Churchyard

In Conversation With... Kelly Dooley and Gavin Churchyard

The Lancet HIV